EIN 86-0818253

International Cancer Advocacy Network (ICAN)

IRS 501(c) type
501(c)(3)
Num. employees
1
State
Year formed
1995
Most recent tax filings
2022-12-01
NTEE code, primary
Description
International Cancer Advocacy Network provides late-stage cancer patients with advocacy, information and strategic options. Patients can benefit from the case management, clinical trials and molecular profiling options available across the US and in 53 countries. Ican connects patients with world-class specialists and cutting-edge referrals to explore alternative treatment modalities.
Total revenues
$1,357,826
2022
Total expenses
$915,666
2022
Total assets
$3,351,569
2022
Num. employees
1
2022

Program areas at ICAN

Ican patient services, including research Advocacy programs of which 290,000 in grants were awarded to the university of Texas md anderson Cancer center, the university of Pennsylvania, johns hopkins, and the university of California san francisco for projects relating to molecular alterations/resistance mechanisms, drug development w/ new mechanisms of action, early detection assays, & leptomeningeal disease. These projects cover two molecular alterations present in more than twenty-five separate tumor types each (egfr exon 20 insertions and her2 exon 20 insertions). Our patient services/oncology nursing services focus on hematological, solid tumor, synchronous/rare cancers; protocol review, & side effects mitigation.
Molecular profiling connection services/clinical trials matching services--advising patients on the importance of next-generation sequencing and molecular profiling (genomics, proteomics, transcriptomics, and immune cell studies); reviewing molecular profiling reports with patients and their care partners, convening ad hoc molecular tumor boards where needed; connecting patients to principal investigators and study teams on pan- tumor/pan-heme/pan-rare Cancer basis. The organization specializes in clinical trial accrual and retention issues as well as clinical trials site selection issues. Ongoing work on decentralizing trials and just-in-time trial concepts as well as transferring patients from one clinical trials site to another more convenient site.
Patient, care partner, and clinician education/ u.s. and global patient access programs-focusing on patient access to molecular testing and precision medicine; u.s. and global health equity issues; early detection (imaging and molecular diagnostics); ongoing health information projects; and access issues regarding expanded access/pre-approval access/compassionate use programs in the u.s. and countries outside the u.s.

Grants made by ICAN

GranteeGrant descriptionAmount
University of Pennsylvania (Penn)Immunotherapy Resrch$52,500
Lung Cancer Research Foundation (LCRF)Ucsf Grant$37,500
Johns Hopkins University (JHU)Cancer Research$20,000

Who funds International Cancer Advocacy Network (ICAN)

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
The Larry and Cathy Becker Family FoundationCancer Advocacy$128,820
Goldman Sachs Philanthropy Fund (GSPF)Medical$25,000
Vanguard Charitable Endowment ProgramFor Recipient's Exempt Purpose$15,500
...and 11 more grants received

Personnel at ICAN

NameTitleCompensation
Marcia K HornPresident and Chief Executive Officer$172,000
Cheryl J Hintzen-GainesChair - Honora / Chair Honorary Trustees / Chair , Honor$0
Cathy DalzellEvent Chair / Chair , Ican Leadership Council / Chair Adivis / Chair Advisory Council / Chair , Advis$0
Robert H Tamis Decd NovVice Chair S$0
Sidney M RosenChairman$0
...and 4 more key personnel

Financials for ICAN

RevenuesFYE 12/2022
Total grants, contributions, etc.$1,378,104
Program services$0
Investment income and dividends$3,327
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$-4,644
Net income from fundraising events$-18,961
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$1,357,826

Form 990s for ICAN

Fiscal year endingDate received by IRSFormPDF link
2022-122023-11-13990View PDF
2021-122022-11-03990View PDF
2020-122021-11-15990View PDF
2019-122022-01-18990View PDF
2018-122019-12-30990View PDF
...and 11 more Form 990s
Data update history
January 4, 2024
Posted financials
Added Form 990 for fiscal year 2022
January 3, 2024
Updated personnel
Identified 1 new personnel
December 28, 2023
Received grants
Identified 3 new grant, including a grant for $11,000 from Central New York Community Foundation
December 25, 2023
Used new vendors
Identified 1 new vendor, including
August 17, 2023
Posted financials
Added Form 990 for fiscal year 2020
Nonprofit Types
Grantmaking organizationsDisease research fundraisersDisease-focused nonprofitsCharities
Issues
HealthMental healthDiseases and disordersCancer
Characteristics
Conducts researchFundraising eventsCommunity engagement / volunteeringTax deductible donations
General information
Address
27 W Morten Ave
Phoenix, AZ 85021
Metro area
Phoenix-Mesa-Chandler, AZ
County
Maricopa County, AZ
Website URL
askican.org/ 
Phone
(602) 618-0183
IRS details
EIN
86-0818253
Fiscal year end
December
Taxreturn type
Form 990
Year formed
1995
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
G30: Cancer
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent
Free account sign-up

Want updates when ICAN has new information, or want to find more organizations like International Cancer Advocacy Network (ICAN)?

Create free Cause IQ account